CIK 0000095953 · Chemicals & Allied Products (SIC 2800) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 74.9 M | 193.2 M | 262.0 M |
| Net income (USD) | 867000 | -26.6 M | 22.1 M |
| Diluted EPS (USD/shares) | 0.09 | -2.63 | 2.12 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-08-26 | 8-K | 8-K items 7.01,9.01 | 2026-08-26 |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-27 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-21 | 8-K | 8-K items 1.01,9.01 | 2026-07-17 |
| 2026-06-29 | 8-K | 8-K items 8.01 | 2026-06-29 |
| 2026-06-29 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-10 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-10 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-10 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-10 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-10 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-10 |
| 2026-06-10 | 8-K | 8-K items 5.07 | 2026-06-10 |
| 2026-05-20 | 3 | FORM 3 | 2026-05-04 |
| 2026-05-20 | 3 | FORM 3 | 2026-05-04 |
| 2026-05-18 | 8-K | 8-K items 7.01,9.01 | 2026-05-18 |
| 2026-05-06 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-06 | 8-K | 8-K items 1.01,2.01,2.02,7.01,9.01 | 2026-05-04 |
| 2026-04-30 | DEFA14A | DEFA14A | |
| 2026-04-30 | DEF 14A | DEF 14A | 2026-06-10 |
| 2026-04-09 | EFFECT | EFFECT items ,, | |
| 2026-04-08 | 4 | FORM 4 | 2026-04-01 |
| 2026-04-08 | 3 | FORM 3 | 2026-04-01 |
Forms on file (last 1,000): 4 440, 8-K 193, 10-Q 47, 3 45, SC 13G/A 34, DFAN14A 28, DEFA14A 26, SC 13D/A 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ACNT (0.002 USD), /gw/filings/filings?ticker=ACNT&form=8-K, /gw/filings/facts?ticker=ACNT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange